PITTSBURGH, June 20 /PRNewswire/ -- CardiacAssist, Inc., announced that it has placed the TandemHeart(R) PTVA(R) System at three new medical centers. More than 100 hospitals across the U.S. and more than 120 worldwide now use the TandemHeart System for extracorporeal support.
The three new CardiacAssist Centers of Excellence are:
-- Duke University Medical Center in Durham, N.C.
-- NYU Medical Center in New York, N.Y.
-- INTEGRIS Heart Hospital in Oklahoma City, Okla.
The TandemHeart System provides extracorporeal circulatory support through a percutaneous cardiac catheterization procedure in as little as 30 minutes. The resulting increase in blood flow is up to five liters per minute (lpm).
"We're pleased to have such prestigious cardiac care facilities join our centers of excellence that are now using the TandemHeart System," said Michael Garippa, president and CEO of CardiacAssist. "The adoption rate for this technology continues to increase, and our clinical experience with the TandemHeart will soon surpass 1000 uses."
Duke University Medical Center is the leading medical center in the Southeast, with a medical school ranked among the top three in the nation.
NYU Medical Center consistently ranks among the nation's top hospitals in U.S. News & World Report's guide to "America's Best Hospitals," and it has been ranked among the top three overall best hospitals in the New York City Metro Area in New York Magazine's "Best Hospitals" survey. INTEGRIS Heart Hospital is the largest and most comprehensive cardiac program in Oklahoma and has been named by HCIA, Inc. as one of the Top 100 Heart Hospitals in the U.S.
The TandemHeart System is now in use at all twenty of the top heart and heart surgery hospitals, as reported by the U.S. News and World Report.
The TandemHeart System is designed to be used as an extracorporeal circulatory support system for procedures not requiring complete cardiopulmonary bypass. The device has received FDA 510(k) clearance for use for up to six hours and is the only FDA approved device of its kind in the U.S.
The TandemHeart System is fully reimbursed by Medicare under existing DRG codes. The device can be placed rapidly in the cath lab or operating room, providing effective, reliable, temporary circulatory support. To date, the TandemHeart System has been used in 28 countries at 120 different facilities by 150 different physicians.
About CardiacAssist
Founded in 1996, CardiacAssist, Inc. is a privately held, Pittsburgh-based medical device company that develops, manufactures and markets innovative products designed to provide cardiologists and cardiac surgeons with minimally invasive solutions for providing extracorporeal circulatory support. Its vision is to help advance the treatment of heart disease by bridging gaps in current treatment methodologies.
This press release may contain certain forward-looking statements that relate to CardiacAssist's future business and financial performance. Such statements are subject to a number of risks and uncertainties that may cause the actual events or future results to differ from those discussed herein.
CardiacAssist, Inc.CONTACT: Dan Snyders of Armada Medical Marketing for CardiacAssist, Inc.,303-623-1190 x230, dan@armadamedical.com; or Monica Bush of CardiacAssist,Inc., 412-963-7770 x247, mbush@cardiacassist.com
Web site: http://www.cardiacassist.com//
